Use of a combined biofeedback-virtual reality (VR) device reduces acute medication use in patients with chronic migraine, according to new study findings presented at AAN 2022.
Behavioral therapy, including biofeedback, has been shown to improve outcomes in episodic migraine, said the researchers from the University of Washington in Seattle, Washington, USA.